Dr Krebs is a Clinical Senior Lecturer in Experimental Cancer Medicine at The University of Manchester and Consultant in Medical Oncology at The Christie NHS Foundation Trust, Manchester, UK. Dr Krebs expertise is in early-phase clinical trials with interests in drug development for lung cancer and precision medicine.
His translational research focuses on the clinical application of circulating tumour DNA to guide personalised treatment selection and to monitor treatment response and resistance. He has been Principal or Chief Investigator on >40 and co-investigator on >75 early phase clinical trials across a broad range of novel therapies.
He is lead for Precision Medicine at The Christie NHS Foundation Trust within the Experimental Cancer Medicine Team, Chief Investigator of the TARGET Precision Medicine program, Chair of the Manchester Molecular Tumour Board and co-theme lead for Clinical Trials within the CRUK Manchester-UCL Lung Cancer Centre of Excellence.
EM-40026 - Date of preparation: August 2020